Matches in SemOpenAlex for { <https://semopenalex.org/work/W1504080602> ?p ?o ?g. }
- W1504080602 endingPage "11" @default.
- W1504080602 startingPage "1" @default.
- W1504080602 abstract "Background Coronary heart disease (CHD) risk increases with age; yet lipid-lowering therapies are significantly under-utilized in patients > 65 years. The objective was to evaluate the safety and efficacy of lipid-lowering therapies in older patients treated with atorvastatin 10 mg + ezetimibe 10 mg (EZ/Atorva) vs. increasing the atorvastatin dose to 40 mg. Methods Patients ≥ 65 years with atherosclerotic vascular disease (LDL-C ≥ 1.81 mmol/L) or at high risk for coronary heart disease (LDL-C ≥ 2.59 mmol/L) were randomized to EZ/Atorva for 12 wk vs. uptitration to atorvastatin 20 mg for 6 wk followed by atorvastatin 40 mg for 6 wk. The percent change in LDL-C and other lipid parameters and percent patients achieving prespecified LDL-C levels were assessed after 12 wk. Results EZ/Atorva produced greater reductions in most lipid parameters vs. uptitration of atorvastatin in patients ≥ 75 years (n = 228), generally consistent with patients 65–74 years (n = 812). More patients achieved LDL-C targets with combination therapy vs. monotherapy in both age groups at 6 wk and in patients ≥ 75 years at 12 wk. At 12 wk, more patients ≥ 75 years achieved LDL-C targets with monotherapy vs. combination therapy. EZ/Atorva produced more favorable improvements in most lipids vs. doubling or quadrupling the atorvastatin dose in patients ≥ 75 years, generally consistent with the findings in patients 65–74 years. Conclusions Our results extended previous findings demonstrating that ezetimibe added to a statin provided a generally well-tolerated therapeutic option for improving the lipid profile in patients 65 to 74 years and ≥ 75 years of age." @default.
- W1504080602 created "2016-06-24" @default.
- W1504080602 creator A5008209592 @default.
- W1504080602 creator A5009971196 @default.
- W1504080602 creator A5028635098 @default.
- W1504080602 creator A5039756526 @default.
- W1504080602 creator A5046037086 @default.
- W1504080602 creator A5074860045 @default.
- W1504080602 creator A5077955682 @default.
- W1504080602 creator A5081512523 @default.
- W1504080602 creator A5090460841 @default.
- W1504080602 date "2011-04-15" @default.
- W1504080602 modified "2023-10-18" @default.
- W1504080602 title "The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years" @default.
- W1504080602 cites W1852619392 @default.
- W1504080602 cites W1962264436 @default.
- W1504080602 cites W1998391689 @default.
- W1504080602 cites W2001375687 @default.
- W1504080602 cites W2002426975 @default.
- W1504080602 cites W2025041596 @default.
- W1504080602 cites W2055674320 @default.
- W1504080602 cites W2058444692 @default.
- W1504080602 cites W2075543662 @default.
- W1504080602 cites W2104982711 @default.
- W1504080602 cites W2111385165 @default.
- W1504080602 cites W2111597641 @default.
- W1504080602 cites W2123793996 @default.
- W1504080602 cites W2135631433 @default.
- W1504080602 cites W2149043451 @default.
- W1504080602 cites W4238251256 @default.
- W1504080602 doi "https://doi.org/10.3724/sp.j.1263.2011.00001" @default.
- W1504080602 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3390058" @default.
- W1504080602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22783278" @default.
- W1504080602 hasPublicationYear "2011" @default.
- W1504080602 type Work @default.
- W1504080602 sameAs 1504080602 @default.
- W1504080602 citedByCount "11" @default.
- W1504080602 countsByYear W15040806022012 @default.
- W1504080602 countsByYear W15040806022013 @default.
- W1504080602 countsByYear W15040806022014 @default.
- W1504080602 countsByYear W15040806022015 @default.
- W1504080602 countsByYear W15040806022016 @default.
- W1504080602 countsByYear W15040806022018 @default.
- W1504080602 countsByYear W15040806022023 @default.
- W1504080602 crossrefType "journal-article" @default.
- W1504080602 hasAuthorship W1504080602A5008209592 @default.
- W1504080602 hasAuthorship W1504080602A5009971196 @default.
- W1504080602 hasAuthorship W1504080602A5028635098 @default.
- W1504080602 hasAuthorship W1504080602A5039756526 @default.
- W1504080602 hasAuthorship W1504080602A5046037086 @default.
- W1504080602 hasAuthorship W1504080602A5074860045 @default.
- W1504080602 hasAuthorship W1504080602A5077955682 @default.
- W1504080602 hasAuthorship W1504080602A5081512523 @default.
- W1504080602 hasAuthorship W1504080602A5090460841 @default.
- W1504080602 hasBestOaLocation W15040806021 @default.
- W1504080602 hasConcept C126322002 @default.
- W1504080602 hasConcept C126894567 @default.
- W1504080602 hasConcept C164705383 @default.
- W1504080602 hasConcept C2776329913 @default.
- W1504080602 hasConcept C2776839432 @default.
- W1504080602 hasConcept C2777482532 @default.
- W1504080602 hasConcept C2778163477 @default.
- W1504080602 hasConcept C2778270857 @default.
- W1504080602 hasConcept C2778657065 @default.
- W1504080602 hasConcept C3018906752 @default.
- W1504080602 hasConcept C71924100 @default.
- W1504080602 hasConcept C90924648 @default.
- W1504080602 hasConcept C98274493 @default.
- W1504080602 hasConceptScore W1504080602C126322002 @default.
- W1504080602 hasConceptScore W1504080602C126894567 @default.
- W1504080602 hasConceptScore W1504080602C164705383 @default.
- W1504080602 hasConceptScore W1504080602C2776329913 @default.
- W1504080602 hasConceptScore W1504080602C2776839432 @default.
- W1504080602 hasConceptScore W1504080602C2777482532 @default.
- W1504080602 hasConceptScore W1504080602C2778163477 @default.
- W1504080602 hasConceptScore W1504080602C2778270857 @default.
- W1504080602 hasConceptScore W1504080602C2778657065 @default.
- W1504080602 hasConceptScore W1504080602C3018906752 @default.
- W1504080602 hasConceptScore W1504080602C71924100 @default.
- W1504080602 hasConceptScore W1504080602C90924648 @default.
- W1504080602 hasConceptScore W1504080602C98274493 @default.
- W1504080602 hasIssue "1" @default.
- W1504080602 hasLocation W15040806021 @default.
- W1504080602 hasLocation W15040806022 @default.
- W1504080602 hasLocation W15040806023 @default.
- W1504080602 hasLocation W15040806024 @default.
- W1504080602 hasOpenAccess W1504080602 @default.
- W1504080602 hasPrimaryLocation W15040806021 @default.
- W1504080602 hasRelatedWork W132670735 @default.
- W1504080602 hasRelatedWork W1973567151 @default.
- W1504080602 hasRelatedWork W1980695468 @default.
- W1504080602 hasRelatedWork W2020687765 @default.
- W1504080602 hasRelatedWork W2032483368 @default.
- W1504080602 hasRelatedWork W2052783404 @default.
- W1504080602 hasRelatedWork W2751176954 @default.
- W1504080602 hasRelatedWork W2900848740 @default.
- W1504080602 hasRelatedWork W2904558057 @default.
- W1504080602 hasRelatedWork W37687202 @default.